Skip to main content
. 2014 Aug 6;4(8):e005593. doi: 10.1136/bmjopen-2014-005593

Table 1.

Characteristics of the patients with Hymenoptera venom allergy treated with VIT, with or without work disability

Participants with work disability
n=31
Participants without work disability
n=150
p Value
Female, n (%) 6 (19.4) 37 (24.7) NS
Age, mean±SD 49.4±9.9 47.1±10.9 NS
Living in the countryside, n (%) 20 (64.5) 98 (65.3) NS
VIT, n (%)
 Ongoing 21 (67.7) 101 (67.3) NS
 Concluded 10 (32.2) 49 (67.3)
Treated with VIT for, n (%)
Apis mellifera 11 (35.5) 48 (32) NS
Vespula sp. 14 (45.2) 52 (34.7) NS
Polistes sp. 3 (9.7) 38 (25.3) NS
Vespa crabro 3 (9.7) 12 (8) NS
Type of VIT extract
 Aqueous 23 (74.2) 104 (69.3) NS
 Depot 8 (25.8) 46 (30.7)
Mueller reaction grade, n (%)
 I 6 (19.4) 27 (18) NS
 II 4 (12.9) 30 (20)
 III 7 (22.6) 30 (20)
 IV 14 (45.2) 63 (42)
Ever stung before the reaction, n (%) 26 (83.9) 110 (73.3) NS
Other severe Hymenoptera reactions, n (%) 1 (3.2) 12 (8) NS
Years after the first severe reaction, mean±SD 9±6.7 7.1±5.7 NS
Having the severe reaction, n (%)
 At work 14 (45.2) 26(17.3) <0.01
 During sport 1 (3.2) 4 (2.7) NS
 During hobby activity 9 (29) 52 (34.7) NS
 At home 6 (19.4) 44 (29.3) NS
 In car/motorcycle 3 (9.7) 24 (16) NS
Work-related risk of exposure to Hymenoptera, n (%)
 High 21 (67.7) 53 (35.3) <0.01
 Occasionally high 5 (16.1) 35 (23.3)
 Low 5 (16.1) 62 (41.3)
Self-employed worker, n (%) 6 (51.6) 42 (28) <0.01

NS, not significant; VIT, venom immunotherapy.